Zimmer Biomet Holdings, Inc. (ZBH) Q2 2019 Earnings Results

Zimmer Biomet Beats on EPS, Stock Up 8.55%

Zimmer Biomet's strong EPS performance exceeded expectations, leading to an 8.55% increase in stock price. The positive reaction reflects investor confidence in the company's operational strength and future potential. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.93	N/A	+1.07%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their strategic direction. They acknowledged ongoing market pressures but remain focused on long-term growth.

Management highlighted strong operational performance despite market challenges.

They emphasized their commitment to innovation and product development.

Zimmer Biomet Beats on EPS, Stock Up 8.55%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Beats on EPS, Stock Up 8.55%

Key numbers

Management commentary